Prostate SBRT (5-Session Treatment)
Stereotactic Body Radiotherapy delivering curative radiation in just 5 outpatient sessions instead of 4 to 8 weeks.
A curative prostate cancer treatment completed in 5 convenient outpatient visits.
Prostate Stereotactic Body Radiotherapy (SBRT) represents one of the most significant advancements in genitourinary oncology over the past decade, supported by mature 10-year data from trials such as PACE-B and HYPO-RT-PC.
Because prostate cancer cells have high sensitivity to large radiation doses per fraction (low alpha/beta ratio), delivering 35–37.5 Gy in 5 fractions over 1 to 2 weeks produces outstanding tumor control while dramatically shortening treatment duration.
Treatment utilizes sub-millimeter image guidance (CBCT) and strict bladder and bowel filling protocols to ensure the radiation beam tracks the prostate precisely during each 15-minute session.
Key Clinical Considerations in Your Consultation
Every recommendation is customized according to staging scans, pathology markers, and patient priorities.
Eligibility assessment using PSA, biopsy grade, and mpMRI staging
5-session treatment schedule delivered over 10 to 14 days on an outpatient basis
Sub-millimeter real-time image guidance and intra-fraction motion control
Protection of the bladder neck, neurovascular bundles, and rectal wall
Rapid return to daily professional and family activities without hospital stay
Comparing 5-day SBRT with robotic radical prostatectomy
Discuss Prostate SBRT (5-Session Treatment)
Bring biopsy reports, recent PET/CT or MRI scans, and operative summaries for a comprehensive consultation.